SIRT2 transgenic over-expression does not impact lifespan in mice

Area of Science:

• Gerontology
• Molecular Biology
• Biochemistry

Background:

• Sirtuin-2 (SIRT2), an NAD+-dependent deacylase, is implicated in aging and lifespan.
• SIRT2 overexpression in progeria models improves health and lifespan by stabilizing BubR1.
• The role of SIRT2 in aging outside of specific progeria models remains unclear.

Purpose of the Study:

• To investigate the impact of SIRT2 overexpression on the health and lifespan of wild-type mice.
• To determine if SIRT2 influences aging processes in a non-progeroid background.

Main Methods:

• Generation of SIRT2 transgenic (SIRT2-Tg) mice on a wild-type background.
• Assessment of health and lifespan in male and female mice on standard chow and high-fat diets.
• Biochemical analysis using NMR to study metabolite levels in the brain.

Main Results:

• SIRT2 overexpression did not significantly impact the overall health or lifespan of wild-type mice.
• No additional benefits on health or lifespan were observed in either sex or under dietary challenges.
• NMR studies revealed altered brain metabolite levels in SIRT2-Tg mice, but without functional consequences.

Conclusions:

• SIRT2 overexpression in wild-type mice does not confer benefits in terms of healthspan or lifespan.
• Metabolic alterations observed in the brain do not translate to functional improvements.
• Strategies aimed at increasing SIRT2 protein levels may not be effective for promoting longevity.